HER2 imaging in the ZEPHIR study

Ann Oncol. 2016 Apr;27(4):555-7. doi: 10.1093/annonc/mdw033. Epub 2016 Jan 22.

Authors

A S Clark¹, A DeMichele², D Mankoff³

Affiliations

¹ Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center amy.clark@uphs.upenn.edu.
² Department of Medicine, Division of Hematology/Oncology, Abramson Cancer Center Center for Clinical Epidemiology and Biostatistics.
³ Division of Nuclear Medicine, Department of Radiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA.

PMID: 26802154
DOI: 10.1093/annonc/mdw033

No abstract available

Publication types

Editorial
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Comment

MeSH terms

Diagnostic Imaging*
Humans
Receptor, ErbB-2*

Substances

Receptor, ErbB-2

Grants and funding

P30 CA016520/CA/NCI NIH HHS/United States